The Global Fund, Governance and Public Health
| WEBINAR |
Thursday, June 27, 2019
1pm ET - 2pm ET
In May, Annals of Global Health published a Special Collection exploring the intersection between governance and public health.
Governance and public health are key pillars of modern societies. When governance is fair, effective, and equitable, levels of population health are high, life span is long, infectious diseases are controlled and the environment is protected. And when governance fails, public health crumbles. It is no accident that the last case of smallpox occurred in war-torn Somalia, or that measles is epidemic today in Pakistan and polio in Syria.
The reports in this Special Collection by Matthew Kavanagh and Lixue Chen of Georgetown University and the accompanying essay by Ambassador Eric Goosby, now at UCSF demonstrate with great clarity that the relationship between governance and public health is bidirectional. Not only does good governance promote public health. Sustained, multi-year public health aid also strengthens governance. Kavanagh and Chan show in a review of data from 112 countries that long-term support of public health institutions in developing countries by the Global Fund to Fight AIDS, Tuberculosis and Malaria strengthens societal institutions, reduces corruption and advances development. Ambassador Goosby's Commentary further elaborates the theme and puts it in broad perspective.
These important papers show us once again that support for public health is not a cost but an investment in the future. Join us on June 27 when we discuss the what happens, and what needs to happen on the crossroads of governance and public health.
The Global Fund, Governance and Pubic Health
| Moderator |
Philip J. Landrigan, MD, MSc, FAAP is a pediatrician and epidemiologist. He is Professor of Biology and Director of the Global Public Health Program at Boston College and Professor Emeritus of Preventive Medicine and Pediatrics in the Icahn School of Medicine at Mount Sinai.
For four decades, Dr. Landrigan has been a leader in children’s environmental health. His early studies of lead poisoning demonstrated that lead is toxic to children even at very low levels and contributed to the US government’s decision to remove lead from paint and gasoline; this decision that led to a more than 90% reduction in blood lead levels across the United States and a subsequent 5-point increase in American children’s mean IQ score. A study he led at the National Academy of Sciences in the early 1990’s defined children’s unique susceptibilities to pesticides and other toxic chemicals, catalyzed fundamental revamping of US pesticide policy and led to passage of the Food Quality Protection Act of 1996, the only federal environmental law that contains provisions explicitly protecting children’s health. He guided EPA in establishing the Office of Children's Health Protection.
From 2015-2017, Dr. Landrigan co-chaired the Lancet Commission on Pollution & Health whose report found that pollution causes 9 million deaths annually and is an existential threat to planetary health. To continue the work of the Lancet Commission, Dr. Landrigan directs the Global Observatory on Pollution and Health at Boston College.
Dr. Landrigan graduated from Boston Latin School (1959), Boston College (1963), Harvard Medical School (1967) and the London School of Hygiene & Tropical Medicine (1977). He completed a residency in pediatrics at Children’s Hospital Boston. He trained in epidemiology at the Centers for Disease Control and Prevention and served for 15 years as a CDC epidemiologist. He later served in the Medical Corps of the US Navy and retired at the rank of Captain. He is a member of the National Academy of Medicine.
The Global Fund, Governance and Pubic Health
| Speakers |
Dr. Eric Goosby, MD, is a Professor of Medicine and Director of Global Health Delivery and Diplomacy, Institute for Global Health Sciences, at the University of California, San Francisco.
In January 2015, Dr. Goosby was appointed by UN Secretary-General Ban Ki-moon to be the UN Special Envoy on Tuberculosis (TB). From 2009-2013, he served in the Obama Administration as Ambassador-at-Large and U.S. Global AIDS Coordinator, overseeing the implementation of the President’s Emergency Plan for AIDS Relief (PEPFAR), and also led the State Department’s Office of Global Health Diplomacy.
Dr. Matthew Kavanagh, PhD, is visiting professor at Georgetown University Law Center and director of the Global Health Policy and Governance Initiative at the O’Neill Institute.
A political scientist by training, with extensive experience working in policy and human rights, he works at the intersection of global health, law, and political economy. Dr. Kavanagh’s research and policy work focuses on the drivers of access to healthcare and medicines in low- and middle-income countries and the impact of human rights and constitutional protections on health outcomes. He also serves as a member of the UNAIDS Scientific & Technical Advisory Committee and has advised various international organizations and NGOs on global health policy. He also leads a new project entitled the HIV Policy Lab that is tracking and supporting change in the HIV-related policy environment in countries around the world.
Dr. Sara L.M. Davis (Meg), PhD, senior fellow at the Graduate Institute’s Global Health Centre and Anthropology & Sociology department, has twenty years’ experience in anthropology, health and human rights as a scholar and practitioner.
She earned her PhD at the University of Pennsylvania, where she taught BA courses on China, and held postdoctoral fellowships at Yale University and UCLA. Her book, Song and Silence: Ethnic Revival on China’s Southwest Borders (Columbia University Press 2005), was based on ethnographic fieldwork in Yunnan and Myanmar. As a researcher at Human Rights Watch and, later, founding executive director of Asia Catalyst, she worked in partnership with dozens of community-based organizations on human rights training, research and advocacy. She was the first senior advisor on human rights at The Global Fund to Fight AIDS, TB and Malaria, where she led early work to operationalize the Fund’s strategic objective on human rights.